Jazz Pharmaceuticals JAZZ Change in estimate, amount
Change in estimate, amount at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept jazz:EffectiveIncomeTaxRateReconciliationChangeInEstimateAmount.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's change in estimate, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's change in estimate, amount?
- Jazz Pharmaceuticals (JAZZ) reported change in estimate, amount of -$26.5M in Q4 2024.
- How has Jazz Pharmaceuticals's change in estimate, amount changed year-over-year?
- Jazz Pharmaceuticals's change in estimate, amount decreased by 1837.3% year-over-year, from -$1.37M to -$26.5M.
- What is the long-term trend for Jazz Pharmaceuticals's change in estimate, amount?
- Over 3 years (2021 to 2024), Jazz Pharmaceuticals's change in estimate, amount has grown at a 241.9% compound annual growth rate (CAGR), from -$2.65M to -$106.01M.
- What does change in estimate, amount mean?
- The financial impact of updating previous tax-related accounting estimates.
- How do you interpret change in estimate, amount?
- Frequent large adjustments may signal poor forecasting or significant volatility in the company's tax planning environment.
- How does change in estimate, amount compare across companies?
- Standard line item in effective tax rate reconciliations across all industries.